FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896564063> ?p ?o ?g. }

• W2896564063 endingPage "e348" @default.
• W2896564063 startingPage "e342" @default.
• W2896564063 abstract "The objective of our study was to describe the local control (LC) outcomes with 3- or 5-fraction stereotactic body radiotherapy (SBRT) to the spine in patients with oligometastatic (≤5 systemic metastases) versus polymetastatic disease (>5 metastases).We retrospectively reviewed the outcomes of patients who had undergone SBRT for spinal metastases. No patients had undergone previous surgical intervention or had spinal cord compression. All patients were treated with 3-fraction (median dose, 27 Gy; range, 24-30 Gy) or 5-fraction (median dose, 35 Gy; range, 25-40 Gy) SBRT. The Kaplan-Meier method and Spine Response Assessment in Neuro-Oncology criteria were used to determine LC.We included 61 patients with a total of 72 distinct SBRT targets who had been treated from August 2007 to June 2017. The median follow-up period was 13.58 months. We treated 20 targets and 52 targets with 3 and 5 fractions, respectively. Thirteen patients (18.1%) had undergone previous RT to the SBRT area. Twenty patients (35% of the distinct SBRT targets) had an oligometastatic disease state. The 1-year LC rate was 83% for the entire cohort. On univariable analysis, polymetastases (1-year LC, 73.8% vs. 100%; P = 0.07) showed a trend toward worse LC. On multivariable analysis, patients with an oligometastatic state (hazard ratio, 0.21; P = 0.04) had improved LC.Our study was hypothesis-generating in that patients with an oligometastatic disease state appear to have improved LC after SBRT, suggesting a biological advantage exists with local therapy for this group of patients not seen for patients with polymetastatic disease." @default.
• W2896564063 created "2018-10-26" @default.
• W2896564063 creator A5002290071 @default.
• W2896564063 creator A5022357417 @default.
• W2896564063 creator A5034452817 @default.
• W2896564063 creator A5034917210 @default.
• W2896564063 creator A5036860649 @default.
• W2896564063 creator A5056276467 @default.
• W2896564063 creator A5061478990 @default.
• W2896564063 creator A5089082967 @default.
• W2896564063 date "2019-02-01" @default.
• W2896564063 modified "2023-10-11" @default.
• W2896564063 title "Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy" @default.
• W2896564063 cites W1515042192 @default.
• W2896564063 cites W1528207664 @default.
• W2896564063 cites W1823223265 @default.
• W2896564063 cites W1963798982 @default.
• W2896564063 cites W1965531668 @default.
• W2896564063 cites W1965842207 @default.
• W2896564063 cites W1981361272 @default.
• W2896564063 cites W1994009716 @default.
• W2896564063 cites W1998501448 @default.
• W2896564063 cites W2015107633 @default.
• W2896564063 cites W2018038855 @default.
• W2896564063 cites W2021833771 @default.
• W2896564063 cites W2027673233 @default.
• W2896564063 cites W2033052459 @default.
• W2896564063 cites W2034948055 @default.
• W2896564063 cites W2070204552 @default.
• W2896564063 cites W2071248316 @default.
• W2896564063 cites W2072034139 @default.
• W2896564063 cites W2095719154 @default.
• W2896564063 cites W2110013393 @default.
• W2896564063 cites W2110069491 @default.
• W2896564063 cites W2112657305 @default.
• W2896564063 cites W2130693156 @default.
• W2896564063 cites W2138156952 @default.
• W2896564063 cites W2143853878 @default.
• W2896564063 cites W2158733355 @default.
• W2896564063 cites W2185554757 @default.
• W2896564063 cites W2252644333 @default.
• W2896564063 cites W2465852877 @default.
• W2896564063 cites W2481872490 @default.
• W2896564063 cites W2559911131 @default.
• W2896564063 cites W2566074209 @default.
• W2896564063 cites W2596595145 @default.
• W2896564063 cites W2624107508 @default.
• W2896564063 cites W2753858318 @default.
• W2896564063 cites W4240340450 @default.
• W2896564063 doi "https://doi.org/10.1016/j.wneu.2018.10.044" @default.
• W2896564063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30326310" @default.
• W2896564063 hasPublicationYear "2019" @default.
• W2896564063 type Work @default.
• W2896564063 sameAs 2896564063 @default.
• W2896564063 citedByCount "11" @default.
• W2896564063 countsByYear W28965640632019 @default.
• W2896564063 countsByYear W28965640632020 @default.
• W2896564063 countsByYear W28965640632021 @default.
• W2896564063 countsByYear W28965640632022 @default.
• W2896564063 countsByYear W28965640632023 @default.
• W2896564063 crossrefType "journal-article" @default.
• W2896564063 hasAuthorship W2896564063A5002290071 @default.
• W2896564063 hasAuthorship W2896564063A5022357417 @default.
• W2896564063 hasAuthorship W2896564063A5034452817 @default.
• W2896564063 hasAuthorship W2896564063A5034917210 @default.
• W2896564063 hasAuthorship W2896564063A5036860649 @default.
• W2896564063 hasAuthorship W2896564063A5056276467 @default.
• W2896564063 hasAuthorship W2896564063A5061478990 @default.
• W2896564063 hasAuthorship W2896564063A5089082967 @default.
• W2896564063 hasConcept C118552586 @default.
• W2896564063 hasConcept C126322002 @default.
• W2896564063 hasConcept C126838900 @default.
• W2896564063 hasConcept C141071460 @default.
• W2896564063 hasConcept C155806632 @default.
• W2896564063 hasConcept C167135981 @default.
• W2896564063 hasConcept C207103383 @default.
• W2896564063 hasConcept C2778231337 @default.
• W2896564063 hasConcept C2780387249 @default.
• W2896564063 hasConcept C2780775167 @default.
• W2896564063 hasConcept C44249647 @default.
• W2896564063 hasConcept C509974204 @default.
• W2896564063 hasConcept C71924100 @default.
• W2896564063 hasConcept C72563966 @default.
• W2896564063 hasConceptScore W2896564063C118552586 @default.
• W2896564063 hasConceptScore W2896564063C126322002 @default.
• W2896564063 hasConceptScore W2896564063C126838900 @default.
• W2896564063 hasConceptScore W2896564063C141071460 @default.
• W2896564063 hasConceptScore W2896564063C155806632 @default.
• W2896564063 hasConceptScore W2896564063C167135981 @default.
• W2896564063 hasConceptScore W2896564063C207103383 @default.
• W2896564063 hasConceptScore W2896564063C2778231337 @default.
• W2896564063 hasConceptScore W2896564063C2780387249 @default.
• W2896564063 hasConceptScore W2896564063C2780775167 @default.
• W2896564063 hasConceptScore W2896564063C44249647 @default.
• W2896564063 hasConceptScore W2896564063C509974204 @default.
• W2896564063 hasConceptScore W2896564063C71924100 @default.
• W2896564063 hasConceptScore W2896564063C72563966 @default.
• W2896564063 hasLocation W28965640631 @default.

• next